Mati receives patent for novel punctal drug delivery platform

Mati Therapeutics has been granted a U.S. patent for its nasolacrimal drainage system implants for drug therapy, the company announced in a press release.U.S. patent 8,747,884, entitled “Nasolacrimal Drainage System Implants for Drug Therapy,” covers crucial elements of Mati’s novel punctal plug delivery system for the treatment of ocular indications (PPDS). The design includes mechanisms for retaining the punctal plug in the nasolacrimal system during drug elution, according to the release.

Full Story →